Literature DB >> 11209918

Natriuretic peptides inhibit apoptosis and prolong the survival of serum-deprived PC12 cells.

R R Fiscus1, A W Tu, S B Chew.   

Abstract

Atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) were investigated to determine effects on apoptotic DNA fragmentation and survival in serum-deprived PC12 cells. Both peptides caused prolonged cGMP (but not cAMP) elevations lasting for > or = 6 h. The cGMP elevations were 10-, 50- and 68-fold for ANP and 26-, 100- and 148-fold for BNP at 1, 10 and 100 nM, respectively. BNP caused dose-dependent increases in cell survival rates during 3 days of serum deprivation. BNP (1 nM) increased 24 h survival rate from 36% to 67%. ANP (1 nM), BNP (1 nM) and 8-bromo-cGMP (0.1 mM) inhibited by 74.8%, 46.7% and 86.8%, respectively, the apoptotic DNA fragmentation in serum-deprived PC12 cells, measured by our recently developed quantitative technique using capillary electrophoresis with laser-induced fluorescence detector (CE-LIF). The data suggest prolonged cGMP elevations caused by ANP or BNP inhibit apoptotic DNA fragmentation and prolong the survival of serum-deprived PC12 cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11209918     DOI: 10.1097/00001756-200102120-00003

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

1.  Atrial natriuretic peptide promotes cardiomyocyte survival by cGMP-dependent nuclear accumulation of zyxin and Akt.

Authors:  Takahiro Kato; John Muraski; Yan Chen; Yasuyuki Tsujita; Jason Wall; Christopher C Glembotski; Erik Schaefer; Mary Beckerle; Mark A Sussman
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

2.  Protective effects of YC-1 against glutamate induced PC12 cell apoptosis.

Authors:  Xiaofan Yang; Yucheng Wang; Jia Luo; Shichang Liu; Zhuo Yang
Journal:  Cell Mol Neurobiol       Date:  2010-11-10       Impact factor: 5.046

3.  Preincubation with atrial natriuretic peptide protects NG108-15 cells against the toxic/proapoptotic effects of the nitric oxide donor S-nitroso- N-acetylpenicillamine.

Authors:  Siew Boon Cheng Chew; Pui Ying Leung; Ronald Ray Fiscus
Journal:  Histochem Cell Biol       Date:  2003-08-14       Impact factor: 4.304

4.  C-type natriuretic peptide in Parkinson's disease: reduced secretion and response to deprenyl.

Authors:  E A Espiner; J C Dalrymple-Alford; T C R Prickett; Y Alamri; T J Anderson
Journal:  J Neural Transm (Vienna)       Date:  2013-12-05       Impact factor: 3.575

Review 5.  Intervention for apoptosis in cardiomyopathy.

Authors:  Hiroyuki Yaoita; Yukio Maruyama
Journal:  Heart Fail Rev       Date:  2008-06       Impact factor: 4.214

Review 6.  Natriuretic hormones in brain function.

Authors:  Anastasia Hodes; David Lichtstein
Journal:  Front Endocrinol (Lausanne)       Date:  2014-11-28       Impact factor: 5.555

7.  Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson's Disease via Up-regulation of the Wnt/β-Catenin Pathway.

Authors:  Arianna Colini Baldeschi; Eugenia Pittaluga; Federica Andreola; Simona Rossi; Mauro Cozzolino; Giuseppe Nicotera; Gianluca Sferrazza; Pasquale Pierimarchi; Annalucia Serafino
Journal:  Front Aging Neurosci       Date:  2018-02-01       Impact factor: 5.750

8.  Atrial Natriuretic Peptide Promotes Neurite Outgrowth and Survival of Cochlear Spiral Ganglion Neurons in vitro Through NPR-A/cGMP/PKG Signaling.

Authors:  Fei Sun; Ke Zhou; Ke-Yong Tian; Xin-Yu Zhang; Wei Liu; Jie Wang; Cui-Ping Zhong; Jian-Hua Qiu; Ding-Jun Zha
Journal:  Front Cell Dev Biol       Date:  2021-06-23

9.  Cisplatin alters nitric oxide synthase levels in human ovarian cancer cells: involvement in p53 regulation and cisplatin resistance.

Authors:  E L Leung; M Fraser; R R Fiscus; B K Tsang
Journal:  Br J Cancer       Date:  2008-05-27       Impact factor: 7.640

10.  Atrial natriuretic peptide modulates the proliferation of human gastric cancer cells via KCNQ1 expression.

Authors:  Jia Zhang; Zhilong Zhao; Chao Zu; Haijian Hu; Hui Shen; Mingxin Zhang; Jiansheng Wang
Journal:  Oncol Lett       Date:  2013-06-25       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.